Neonatal hyperthyroidism following intrauterine hypothyroidism.
An infant, whose mother was treated for thyrotoxicosis during pregnancy, appeared normal at birth, but laboratory data were indicative of hypothyroidism. On the sixth day of life the infant had clinical and laboratory evidence of hyperthyroidism. A plan of management is proposed for infants born to thyrotoxic mothers.
D000328:Adult; D005260:Female; D005312:Fetal Blood; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy / Q000209:etiology*; D007037:Hypothyroidism / Q000150:complications*; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000209:etiology*; D007455:Iodine / Q000627:therapeutic use; D008135:Long-Acting Thyroid Stimulator / Q000032:analysis; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011248:Pregnancy Complications / Q000378:metabolism*; D011485:Protein Binding; D013889:Thiouracil / Q000627:therapeutic use; D013960:Thyroid Function Tests; D013972:Thyrotropin / Q000032:analysis; D013974:Thyroxine / Q000097:blood
D013889:Thiouracil; D013972:Thyrotropin; D008135:Long-Acting Thyroid Stimulator; D007455:Iodine; D013974:Thyroxine